Eran Ovadya

Eran Ovadya

Director of Finance/CFO at NUREXONE BIOLOGIC INC.

Net worth: 217 304 $ as of 2026-05-30

Health Technology
Consumer Services
Technology Services

Profile

Currently, Eran Ovadya is an Independent Director at Neural Therapeutics, Inc. since 2024 and Chief Financial Officer at NurExone Biologic, Inc. since 2022.
Formerly, Mr. Ovadya was Chief Financial Officer at Forrest Innovations Ltd., Cannibble Foodtech Ltd., and V.V.T.
Med Ltd. from 2017 to 2021, and Chief Financial Officer at Silexion Therapeutics Ltd. and ProCore Biomed Ltd. from 2020 to 2021.
Education includes undergraduate and MBA degrees from The Open University of Israel.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-11-26 425,000 ( 0.46% ) 201 025 $ 2026-05-30
2026-04-13 813,929 ( 0.48% ) 16 279 $ 2026-01-30

Eran Ovadya active positions

CompaniesPositionStart
NUREXONE BIOLOGIC INC. Director of Finance/CFO 2022-06-14
NEURAL THERAPEUTICS INC. Director/Board Member 2024-12-12

Former positions of Eran Ovadya

CompaniesPositionEnd
Director of Finance/CFO 2021-04-30
CANNIBBLE FOOD-TECH LTD. Director of Finance/CFO 2021-04-30
Director of Finance/CFO 2021-03-31
Director of Finance/CFO 2021-03-31
See the detail of Eran Ovadya's experience

Training of Eran Ovadya

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

2

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Consumer Services

Health Technology

Health Technology

Technology Services

Health Technology

Consumer Non-Durables

Health Technology